Elevance Health, Inc. (ELV) stock
ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3011% below fair value
$400.84−33.09 (-7.63%)
Close on Nov 18, 2026Market cap $86.60BP/E 17.1Yield –
Elevance Health operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
Elevance Health's operating income for the twelve months ending Sep 30, 2026 was $5.43B, down 28.2% year over year. For fiscal 2025 it was $7.20B, down 8.4% from the year before. Over ten years it grew 4.2% a year on average. The highest annual figure on record is $8.50B in fiscal 2023.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.20B | -8.4% |
| FY2024 | Dec 31, 2024 | $7.86B | -7.5% |
| FY2023 | Dec 31, 2023 | $8.50B | +2.6% |
| FY2022 | Dec 31, 2022 | $8.28B | +9.6% |
| FY2021 | Dec 31, 2021 | $7.56B | +18.9% |
| FY2020 | Dec 31, 2020 | $6.36B | +6.0% |
| FY2019 | Dec 31, 2019 | $6.00B | +10.6% |
| FY2018 | Dec 31, 2018 | $5.43B | +30.0% |
| FY2017 | Dec 31, 2017 | $4.18B | -13.0% |
| FY2016 | Dec 31, 2016 | $4.80B | +1.0% |
| FY2015 | Dec 31, 2015 | $4.75B | +7.6% |
| FY2014 | Dec 31, 2014 | $4.42B | +10.4% |
| FY2013 | Dec 31, 2013 | $4.00B | +10.5% |
| FY2012 | Dec 31, 2012 | $3.62B | -4.3% |
| FY2011 | Dec 31, 2011 | $3.78B | -7.2% |
| FY2010 | Dec 31, 2010 | $4.08B | -2.4% |
| FY2009 | Dec 31, 2009 | $4.18B | -3.9% |
| FY2008 | Dec 31, 2008 | $4.35B | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.27B | -2.0% |
| Q2 FY2026 | Jun 30, 2026 | $1.76B | -27.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.09B | -34.2% |
| Q4 FY2025 | Dec 31, 2025 | $309.00M | -54.1% |
| Q3 FY2025 | Sep 30, 2025 | $1.30B | -8.0% |
| Q2 FY2025 | Jun 30, 2025 | $2.43B | -12.3% |
| Q1 FY2025 | Mar 31, 2025 | $3.17B | +5.1% |
| Q4 FY2024 | Dec 31, 2024 | $673.00M | -47.6% |
| Q3 FY2024 | Sep 30, 2024 | $1.41B | -19.8% |
| Q2 FY2024 | Jun 30, 2024 | $2.77B | +5.2% |
| Q1 FY2024 | Mar 31, 2024 | $3.02B | +6.5% |
| Q4 FY2023 | Dec 31, 2023 | $1.28B | +2.0% |
| Q3 FY2023 | Sep 30, 2023 | $1.76B | -22.0% |
| Q2 FY2023 | Jun 30, 2023 | $2.63B | +12.0% |
| Q1 FY2023 | Mar 31, 2023 | $2.83B | +16.6% |
| Q4 FY2022 | Dec 31, 2022 | $1.26B | +0.1% |
| Q3 FY2022 | Sep 30, 2022 | $2.25B | +9.3% |
| Q2 FY2022 | Jun 30, 2022 | $2.35B | +12.7% |
| Q1 FY2022 | Mar 31, 2022 | $2.43B | +12.3% |
| Q4 FY2021 | Dec 31, 2021 | $1.26B | +107.9% |
| Q3 FY2021 | Sep 30, 2021 | $2.06B | +924.4% |
| Q2 FY2021 | Jun 30, 2021 | $2.08B | -38.1% |
| Q1 FY2021 | Mar 31, 2021 | $2.16B | -1.5% |
| Q4 FY2020 | Dec 31, 2020 | $605.00M | -44.9% |
| Q3 FY2020 | Sep 30, 2020 | $201.00M | -86.8% |
| Q2 FY2020 | Jun 30, 2020 | $3.36B | +134.5% |
| Q1 FY2020 | Mar 31, 2020 | $2.19B | +13.1% |
| Q4 FY2019 | Dec 31, 2019 | $1.10B | +46.4% |
| Q3 FY2019 | Sep 30, 2019 | $1.53B | +22.3% |
| Q2 FY2019 | Jun 30, 2019 | $1.43B | -8.1% |
| Q1 FY2019 | Mar 31, 2019 | $1.94B | +3.9% |
| Q4 FY2018 | Dec 31, 2018 | $750.00M | +96.9% |
| Q3 FY2018 | Sep 30, 2018 | $1.25B | +27.2% |
| Q2 FY2018 | Jun 30, 2018 | $1.56B | +27.1% |
| Q1 FY2018 | Mar 31, 2018 | $1.87B | +17.8% |
| Q4 FY2017 | Dec 31, 2017 | $381.00M | -41.6% |
| Q3 FY2017 | Sep 30, 2017 | $982.00M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.23B | – |
| Q1 FY2017 | Mar 31, 2017 | $1.59B | – |
| Q4 FY2016 | Dec 31, 2016 | $652.30M | – |
See a number that looks wrong?